Use of farnesyl protein transferase inhibitor for the preparation of pharmaceutical composition having radiosensitizing properties

摘要

Use of farnesyl protein transferase inhibitor for the preparation of pharmaceutical composition having radiosensitizing properties for administration before, during or after irradiation of a tumour for treating tumour in vivo, wherein farnesyl protein transferase inhibitor is a compound of formula (I), or compound of formula (II), or (III), which is metabolized to compound of formula (I) in vivo, wherein the dotted line represents an optional bond; X is oxygen or sulphur and other symbols have the meaning stated in claims.